DK220789A - Middel og dets anvendelse til mindskning af tnf-bivirkninger - Google Patents

Middel og dets anvendelse til mindskning af tnf-bivirkninger Download PDF

Info

Publication number
DK220789A
DK220789A DK220789A DK220789A DK220789A DK 220789 A DK220789 A DK 220789A DK 220789 A DK220789 A DK 220789A DK 220789 A DK220789 A DK 220789A DK 220789 A DK220789 A DK 220789A
Authority
DK
Denmark
Prior art keywords
side effects
reduce tnf
tnfs
tnf
reduce
Prior art date
Application number
DK220789A
Other languages
English (en)
Other versions
DK220789D0 (da
Inventor
Hubert Heuer
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of DK220789D0 publication Critical patent/DK220789D0/da
Publication of DK220789A publication Critical patent/DK220789A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Paper (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
DK220789A 1988-05-11 1989-05-05 Middel og dets anvendelse til mindskning af tnf-bivirkninger DK220789A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3816169A DE3816169A1 (de) 1988-05-11 1988-05-11 Verwendung und mittel zur verminderung der nebenwirkungen von tnf

Publications (2)

Publication Number Publication Date
DK220789D0 DK220789D0 (da) 1989-05-05
DK220789A true DK220789A (da) 1989-11-12

Family

ID=6354207

Family Applications (1)

Application Number Title Priority Date Filing Date
DK220789A DK220789A (da) 1988-05-11 1989-05-05 Middel og dets anvendelse til mindskning af tnf-bivirkninger

Country Status (13)

Country Link
EP (1) EP0341558B1 (da)
JP (1) JP2709139B2 (da)
KR (1) KR900017592A (da)
AT (1) ATE78695T1 (da)
AU (1) AU614607B2 (da)
CA (1) CA1336825C (da)
DE (2) DE3816169A1 (da)
DK (1) DK220789A (da)
ES (1) ES2042864T3 (da)
GR (1) GR3005387T3 (da)
HU (1) HUT52381A (da)
IL (1) IL90206A0 (da)
ZA (1) ZA893259B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3735525C2 (de) * 1987-10-20 1997-02-20 Korth Ruth Maria Verfahren zur Bestimmung der Wirksamkeit von paf-Acether-Rezeptor-Antagonisten
GB8926611D0 (en) * 1989-11-24 1990-01-17 Xenova Ltd Compound and its use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988002632A1 (en) * 1986-10-16 1988-04-21 President And Fellows Of Harvard College Combinations of tumor necrosis factors and anti-inflammatory agents and methods for treating malignant and non-malignant diseases

Also Published As

Publication number Publication date
JP2709139B2 (ja) 1998-02-04
EP0341558B1 (de) 1992-07-29
KR900017592A (ko) 1990-12-19
DE3816169A1 (de) 1989-11-23
EP0341558A2 (de) 1989-11-15
ZA893259B (en) 1991-01-30
AU3406489A (en) 1989-11-16
DE58901920D1 (de) 1992-09-03
IL90206A0 (en) 1989-12-15
ATE78695T1 (de) 1992-08-15
HUT52381A (en) 1990-07-28
CA1336825C (en) 1995-08-29
AU614607B2 (en) 1991-09-05
GR3005387T3 (da) 1993-05-24
JPH0276825A (ja) 1990-03-16
DK220789D0 (da) 1989-05-05
EP0341558A3 (en) 1990-05-09
ES2042864T3 (es) 1993-12-16

Similar Documents

Publication Publication Date Title
DE69323524D1 (de) Nadelloser Einweg-Injektor
DK376589D0 (da) Engangssproejte
FR2617718B1 (fr) Seringue pre-remplie
IT8848710A0 (it) Siringa monouso
BR8907232A (pt) Seringa hipodermica
DK659388D0 (da) Injektionssproejte
DK238588D0 (da) Anvendelse af 3-(trifluormethylphenoxy)-n-methyl-3-phenylpropylamin til fremstilling af et laegemiddel til behandling af diabetes
DK369385A (da) Middel til behandling af schizofreni
DK332489A (da) Forbindelser med bronkodilatorisk virkning
DK440288D0 (da) Middel til behandling af diabetes mellitus
DK220789D0 (da) Middel og dets anvendelse til mindskning af tnf-bivirkninger
DE69332576T2 (de) Glykolisierte Cytokine
KR900701341A (ko) 일회용 주사기
NO894187D0 (no) Terapeutiske forbindelser.
ATA254988A (de) Einwegspritze
DK85290D0 (da) Terapeutisk virksomme forbindelser
BR8901002A (pt) Mesa giratoria
KR890012452U (ko) 책상상판의 각도 조절장치
DK242989D0 (da) Engangssproejte
ES286012Y (es) Taburete perfeccionado con caracter terapeutico
ATA244088A (de) Einwegspritze
DK162479C (da) Infusionskanyle
KR830003548U (ko) 책상 및 의자 겸용 침대
ITPT920011A0 (it) Siringa con ago rientrante automaticamente
KR890015920U (ko) 책상의 덧판

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment